Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Basis of preparation (Tables)

v3.25.1
Basis of preparation (Tables)
12 Months Ended
Dec. 31, 2024
Basis of preparation.  
Schedule of company's subsidiary

​

​

​

​

​

​

​

Name

    

Place of Incorporation

    

Ownership

 

XORTX Pharma Corp.

 

Canada

 

100%

​